Skip to main content
    Medicines Information Centre logo

Medicines Information Centre

  • Home
  • About us
    • MIC
    • HIV & TB Hotline
  • News
    • News Archive
  • Resources
    • Educational Material/Posters
    • Guidelines
    • SA HIV/TB Hotline App
  • Research
  • Training
  • Contact Us
  • Home
  • About us
  • News
    • News Archive
  • Resources
  • Research
  • Training
  • Contact Us

Breadcrumb

  1. Home

Current news

Our aim with MIC News is to keep you up to date with current issues, including the safety, efficacy and availability of medicines. Please feel free to e-mail us any questions, comments or suggestions.
Withdrawn

Specific factor Xa inhibitor reversal agent withdrawn in USA

The FDA has announced the withdrawal of andexanet alfa, due to concerns that the risks of the product outweigh the benefits based on the results of the ANNEXA-I trial. Andexanet
Read more
Adherence

Interesting insights into adherence vs disease control

Pharmacy Times published an insightful interview discussing the disconnect between objective measurement of adherence and actual clinical outcomes.
Read more
Vaccine

Important finding for future adenovirus vaccines

Scientists from Flinders University in Adelaide, Australia have reported that they have been able to isolate the cause of the rare adverse event known as VITT
Read more

Visit News Archive

Medicines Information Centre logo

Contact Us

Tel: +27 (0)21 406 6829

HIV & TB HCW Hotline: 0800 212 506 or 021 406 6782
Please Call Me/SMS: 071 840 1572

E-mail: pha-mic@uct.ac.za

The information shared on these pages is intended for use by health professionals. It has been compiled from information available to the National HIV & TB Health Care Worker Hotline based at the Medicines Information Centre, and although the greatest care has been taken, the Medicines Information Centre does not accept responsibility for errors or omissions.
  • Facebook
  • LinkedIn
Copyright © - 2026 - University of Cape Town - All rights reserved. POPIA | PAIA.